TGFB1 and osteosarcoma: In osteosarcoma, cisplatin efficacy was reduced upon treatment with exogenous TGF-β 35 Additionally, another study had revealed that cisplatin therapeutic effect on non-small lung cancer cells was reduced by treatment with exogenous TGF-β1 36.